Next Century Growth Investors’s PTC Therapeutics PTCT Stock Holding History

Next Century Growth Investors’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-135,987	Closed	-$3.63M	–	183
2015 Q3	$3.63M	Buy	+135,987	New	+$5.82M	0.15%	135

Other funds holding PTCT

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Next Century Growth Investors's PTCT Position: Q4 2015 in Review

Next Century Growth Investors sold out of PTC Therapeutics (PTCT) in Q4 2015, closing a stake of 135,987 shares — an estimated $3.63M sold.

Next Century Growth Investors first reported a position in PTCT in Q3 2015 and held it in 1 quarter. The position peaked at $3.63M in Q3 2015. 141 funds tracked by Wall St. Rank hold PTCT as of Q4 2015.

Next Century Growth Investors reported no remaining PTC Therapeutics position as of Q4 2015 after selling out during the quarter.
Next Century Growth Investors sold 135,987 PTC Therapeutics shares in Q4 2015, an estimated $3.63M.
Next Century Growth Investors first reported a position in PTC Therapeutics in Q3 2015 and held it in 1 quarter.
Next Century Growth Investors's PTC Therapeutics position peaked at $3.63M in Q3 2015.
141 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2015.

Based on Next Century Growth Investors's 13F filing for Q4 2015, filed 12 Feb 2016.